MediGene

company

About

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

  • 51 - 100

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
€26M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1994
Number Of Employee
51 - 100
Operating Status
Active

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€26M
MediGene has raised a total of €26M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 2, 2022 Post-IPO Equity €26M 1 BioNTech Detail

Investors

Number of Lead Investors
Number of Investors
1
1
MediGene is funded by 1 investors. BioNTech are the most recent investors.
Investor Name Lead Investor Funding Round
BioNTech Yes Post-IPO Equity